[1]
|
Murtha, L.A., Schuliga, M.J., Mabotuwana, N.S., et al. (2017) The Processes and Mechanisms of Cardiac and Pulmonary Fibrosis. Frontiers in Physiology, 8, Article 777. https://doi.org/10.3389/fphys.2017.00777
|
[2]
|
《中国心血管健康与疾病报告2022》编写组. 《中国心血管健康与疾病报告2022》概述[J]. 中国心血管病研究, 2023, 21(7): 577-600.
|
[3]
|
孙亚欣, 尹永杰, 杨文, 张树华. 缺血性心脏病心肌重构的病理基础[J]. 中国实验诊断学, 2005, 9(1): 56-57.
|
[4]
|
李丽娜, 杨敏福. 心血管成纤维细胞显像的现状和展望[J]. 首都医科大学学报, 2024, 45(1): 46-51.
|
[5]
|
Park, S., Nguyen, N.B., Pezhouman, A., et al. (2019) Cardiac Fibrosis: Potential Therapeutic Targets. Translational Research, 209, 121-137. https://doi.org/10.1016/j.trsl.2019.03.001
|
[6]
|
Chen, X., Yang, Q., Bai, W., et al. (2022) Dapagliflozin Attenuates Myocardial Fibrosis by Inhibiting the TGF-β1/Smad Signaling Pathway in a Normoglycemic Rabbit Model of Chronic Heart Failure. Frontiers in Pharmacology, 13, Article 873108. https://doi.org/10.3389/fphar.2022.873108
|
[7]
|
Ponikowska, B., Iwanek, G., Zdanowicz, A., et al. (2022) Biomarkers of Myocardial Injury and Remodeling in Heart Failure. Journal of Personalized Medicine, 12, Article 799. https://doi.org/10.3390/jpm12050799
|
[8]
|
Gotschy, A., Jordan, S., Stoeck, C.T., et al. (2023) Diffuse Myocardial Fibrosis Precedes Subclinical Functional Myocardial Impairment and Provides Prognostic Information in Systemic Sclerosis. European Heart Journal-Cardiovascular Imaging, 24, 373-382. https://doi.org/10.1093/ehjci/jeac094
|
[9]
|
Li, X., Yang, Y., Chen, S., et al. (2021) Epigenetics-Based Therapeutics for Myocardial Fibrosis. Life Sciences, 271, Article 119186. https://doi.org/10.1016/j.lfs.2021.119186
|
[10]
|
López, B., Ravassa, S., Moreno, M.U., et al. (2021) Diffuse Myocardial Fibrosis: Mechanisms, Diagnosis and Therapeutic Approaches. Nature Reviews Cardiology, 18, 479-498. https://doi.org/10.1038/s41569-020-00504-1
|
[11]
|
Kanisicak, O., Khalil, H., Ivey, M.J., et al. (2016) Genetic Lineage Tracing Defines Myofibroblast Origin and Function in the Injured Heart. Nature Communications, 7, Article No. 12260. https://doi.org/10.1038/ncomms12260
|
[12]
|
Umbarkar, P., Ejantkar, S., Tousif, S., et al. (2021) Mechanisms of Fibroblast Activation and Myocardial Fibrosis: Lessons Learned from FB-Specific Conditional Mouse Models. Cells, 10, Article 2412. https://doi.org/10.3390/cells10092412
|
[13]
|
杨晓利, 瞿惠燕, 戎靖枫, 等. 心肌纤维化发病机制的研究进展[J]. 中西医结合心脑血管病杂志, 2020, 18(14): 2255-2258.
|
[14]
|
Ma, Z.G., Yuan, Y.P., Wu, H.M., et al. (2018) Cardiac Fibrosis: New Insights into the Pathogenesis. International Journal of Biological Sciences, 14, 1645-1657. https://doi.org/10.7150/ijbs.28103
|
[15]
|
Li, P.F., He, R.H., Shi, S.B., et al. (2019) Modulation of MiR-10a-Mediated TGF-β1/Smads Signaling Affects Atrial Fibrillation-Induced Cardiac Fibrosis and Cardiac Fibroblast Proliferation. Bioscience Reports, 39, BSR20181931. https://doi.org/10.1042/BSR20181931
|
[16]
|
Zhang, Y.E. (2017) Non-Smad Signaling Pathways of the TGF-β Family. Cold Spring Harbor Perspectives in Biology, 9, a022129. https://doi.org/10.1101/cshperspect.a022129
|
[17]
|
Frangogiannis, N. (2020) Transforming Growth Factor-β in Tissue Fibrosis. Journal of Experimental Medicine, 217, e20190103. https://doi.org/10.1084/jem.20190103
|
[18]
|
Maruyama, K. and Imanaka-Yoshida, K. (2022) The Pathogenesis of Cardiac Fibrosis: A Review of Recent Progress. International Journal of Molecular Sciences, 23, Article 2617. https://doi.org/10.3390/ijms23052617
|
[19]
|
Hinderer, S. and Schenke-Layland, K. (2019) Cardiac Fibrosis—A Short Review of Causes and Therapeutic Strategies. Advanced Drug Delivery Reviews, 146, 77-82. https://doi.org/10.1016/j.addr.2019.05.011
|
[20]
|
Mitchell, M.D., Laird, R.E., Brown, R.D., et al. (2007) IL-1beta Stimulates Rat Cardiac Fibroblast Migration via MAP Kinase Pathways. American Journal of Physiology-Heart and Circulatory Physiology, 292, H1139-H1147. https://doi.org/10.1152/ajpheart.00881.2005
|
[21]
|
Fan, D., Li, L., Wang, C., et al. (2011) Adiponectin Induces Interleukin-6 Production and Its Underlying Mechanism in Adult Rat Cardiac Fibroblasts. Journal of Cellular Physiology, 226, 1793-1802. https://doi.org/10.1002/jcp.22512
|
[22]
|
Yi, X., Li, X., Zhou, Y., et al. (2014) Hepatocyte Growth Factor Regulates the TGF-β1-Induced Proliferation, Differentiation and Secretory Function of Cardiac Fibroblasts. International Journal of Molecular Medicine, 34, 381-390. https://doi.org/10.3892/ijmm.2014.1782
|
[23]
|
Jen, Y., Manova, K. and Benezra, R. (1996) Expression Patterns of Id1, Id2, and Id3 Are Highly Related but Distinct from that of Id4 during Mouse Embryogenesis. Developmental Dynamics, 207, 235-252. https://doi.org/10.1002/(SICI)1097-0177(199611)207:3<235::AID-AJA1>3.0.CO;2-I
|
[24]
|
Izumi, N., Mizuguchi, S., Inagaki, Y., et al. (2006) BMP-7 Opposes TGF-Beta1-Mediated Collagen Induction in Mouse Pulmonary Myofibroblasts through Id2. American Journal of Physiology-Heart and Circulatory Physiology, 290, L120-L126. https://doi.org/10.1152/ajplung.00171.2005
|
[25]
|
Tajima, K., Terai, S., Takami, T., et al. (2007) Importance of Inhibitor of DNA Binding/Differentiation 2 in Hepatic Stellate Cell Differentiation and Proliferation. Hepatology Research, 37, 647-655. https://doi.org/10.1111/j.1872-034X.2007.00089.x
|
[26]
|
Kinoshita, K., Iimuro, Y., Otogawa, K., et al. (2007) Adenovirus-Mediated Expression of BMP-7 Suppresses the Development of Liver Fibrosis in Rats. Gut, 56, 706-714. https://doi.org/10.1136/gut.2006.092460
|
[27]
|
Yang, J., Velikoff, M., Agarwal, M., et al. (2015) Overexpression of Inhibitor of DNA-Binding 2 Attenuates Pulmonary Fibrosis through Regulation of c-Abl and Twist. The American Journal of Pathology, 185, 1001-1011. https://doi.org/10.1016/j.ajpath.2014.12.008
|
[28]
|
Vigolo, E., Markó, L., Hinze, C., et al. (2019) Canonical BMP Signaling in Tubular Cells Mediates Recovery after Acute Kidney Injury. Kidney International, 95, 108-122. https://doi.org/10.1016/j.kint.2018.08.028
|
[29]
|
Xiao, Y., Jiang, X., Peng, C., et al. (2019) BMP-7/Smads-Induced Inhibitor of Differentiation 2 (Id2) Upregulation and Id2/Twist Interaction Was Involved in Attenuating Diabetic Renal Tubulointerstitial Fibrosis. The International Journal of Biochemistry & Cell Biology, 116, Article 105613. https://doi.org/10.1016/j.biocel.2019.105613
|
[30]
|
Lee, H.W., Adachi, T., Pak, B., et al. (2023) BMPR1A Promotes ID2-ZEB1 Interaction to Suppress Excessive Endothelial to Mesenchymal Transition. Cardiovascular Research, 119, 813-825. https://doi.org/10.1093/cvr/cvac159
|
[31]
|
Yin, L., Liu, M., Li, W., et al. (2019) Over-Expression of Inhibitor of Differentiation 2 Attenuates Post-Infarct Cardiac Fibrosis through Inhibition of TGF-β1/Smad3/HIF-1α/IL-11 Signaling Pathway. Frontiers in Pharmacology, 10, Article 1349. https://doi.org/10.3389/fphar.2019.01349
|
[32]
|
刘玉莲, 刘政, 季博, 等. 浅析“心主血脉”理论与闭塞性动脉硬化症相关性[J]. 中国中西医结合外科杂志, 2021, 27(5): 778-781.
|
[33]
|
张露丹, 孙艳君, 刘凡琪, 等. 心力衰竭气虚血瘀证相关生物学标志物研究述评与展望[J]. 天津中医药, 2024, 41(2): 258-263.
|
[34]
|
周曼丽, 俞赟丰, 张宜帆, 等. 基于代谢组学的中药治疗冠心病血瘀证生物标志物分析[J]. 辽宁中医杂志, 2024, 51(2): 17-24.
|
[35]
|
刘颜, 刘孟楠, 杨廷富, 等. 中药防治心肌纤维化的研究进展[J]. 中药药理与临床, 2023, 39(2): 101-109.
|
[36]
|
商行, 郭家娟. 中药单体及复方干预心肌纤维化的作用机制研究[J/OL]. 中国中医基础医学杂志: 1-7. https://doi.org/10.19945/j.cnki.issn.1006-3250.20231115.001, 2024-03-12.
|
[37]
|
杨珊, 赵暖暖, 杨鑫, 等. 人参活性成分及药理作用研究进展[J]. 中医药导报, 2023, 29(1): 105-107, 116.
|
[38]
|
Li, C., Gou, X. and Gao, H. (2021) Doxorubicin Nanomedicine Based on Ginsenoside Rg1 with Alleviated Cardiotoxicity and Enhanced Antitumor Activity. Nanomedicine, 16, 2587-2604. https://doi.org/10.2217/nnm-2021-0329
|
[39]
|
Guan, S., Xin, Y., Ding, Y., et al. (2023) Ginsenoside Rg1 Protects against Cardiac Remodeling in Heart Failure via SIRT1/PINK1/Parkin-Mediated Mitophagy. Chemistry & Biodiversity, 20, e202200730. https://doi.org/10.1002/cbdv.202200730
|
[40]
|
Tian, G., Li, J. and Zhou, L. (2023) Ginsenoside Rg1 Regulates Autophagy and Endoplasmic Reticulum Stress via the AMPK/mTOR and PERK/ATF4/CHOP Pathways to Alleviate Alcohol-Induced Myocardial Injury. International Journal of Molecular Medicine, 52, Article No. 56. https://doi.org/10.3892/ijmm.2023.5259
|
[41]
|
吕丽娜, 姜丽红. 人参皂苷Rg1对心血管系统的药理作用研究进展[J]. 现代中药研究与实践, 2020, 34(6): 83-86.
|
[42]
|
Zhen, J., Bai, J., Liu, J., et al. (2023) Ginsenoside RG1-Induced Mesenchymal Stem Cells Alleviate Diabetic Cardiomyopathy through Secreting Exosomal CircNOTCH1 to Promote Macrophage M2 Polarization. Phytotherapy Research, 38, 1745-1760. https://doi.org/10.1002/ptr.8018
|
[43]
|
Luo, M., Yan, D., Sun, Q., et al. (2020) Ginsenoside Rg1 Attenuates Cardiomyocyte Apoptosis and Inflammation via the TLR4/NF-KB/NLRP3 Pathway. Journal of Cellular Biochemistry, 121, 2994-3004. https://doi.org/10.1002/jcb.29556
|
[44]
|
Qin, Q., Lin, N., Huang, H., et al. (2019) Ginsenoside Rg1 Ameliorates Cardiac Oxidative Stress and Inflammation in Streptozotocin-Induced Diabetic Rats. Diabetes, Metabolic Syndrome and Obesity, 12, 1091-1103. https://doi.org/10.2147/DMSO.S208989
|
[45]
|
Li, L., Pan, C.S., Yan, L., et al. (2018) Ginsenoside Rg1 Ameliorates Rat Myocardial Ischemia-Reperfusion Injury by Modulating Energy Metabolism Pathways. Frontiers in Physiology, 9, Article 78. https://doi.org/10.3389/fphys.2018.00078
|
[46]
|
Xu, Z.M., Li, C.B., Liu, Q.L., et al. (2018) Ginsenoside Rg1 Prevents Doxorubicin-Induced Cardiotoxicity through the Inhibition of Autophagy and Endoplasmic Reticulum Stress in Mice. International Journal of Molecular Sciences, 19, Article 3658. https://doi.org/10.3390/ijms19113658
|